A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab

Clinical Pharmacokinetics
Maria RosarioIrving Fox

Abstract

Vedolizumab is a humanized anti-α4β7 integrin monoclonal antibody that selectively blocks trafficking of memory T cells to inflamed gut tissue by inhibiting the α4β7-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) interaction. Approved for treating patients with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD), vedolizumab is administered as a 300 mg intravenous infusion. Vedolizumab undergoes a rapid, saturable, non-linear, target-mediated elimination process at low concentrations and a slower, linear, non-specific elimination process at higher concentrations. At therapeutic concentrations, vedolizumab primarily undergoes linear elimination. From population pharmacokinetic modeling, the vedolizumab terminal elimination half-life (t ½ β) was estimated to be 25.5 days; linear clearance (CLL) was similar for patients with UC (0.159 L/day) and CD (0.155 L/day). Extreme low albumin concentrations and extreme high body weight values were potentially clinically important predictors of vedolizumab CLL. Other factors, including concomitant therapy use (methotrexate, azathioprine, mercaptopurine, or aminosalicylates) or prior tumor necrosis factor-α (TNF-α) antagonist use, had no clinically relevant ef...Continue Reading

References

Jun 17, 2005·The New England Journal of Medicine·Brian G FeaganMargaret K Vandervoort
Apr 25, 2006·Annals of Neurology·Olaf StüveMichael K Racke
Sep 4, 2007·Journal of Clinical Pharmacology·Kathleen Seitz, Honghui Zhou
Oct 3, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Brian G FeaganAsit Parikh
Apr 28, 2010·International Journal of Clinical Pharmacology and Therapeutics·A A FasanmadeH M Davis
Jul 9, 2010·Clinical Pharmacokinetics·Ron J KeizerJos H Beijnen
Sep 8, 2010·Clinical Pharmacokinetics·Nathanael L Dirks, Bernd Meibohm
Sep 18, 2010·Inflammatory Bowel Diseases·Caihong WangRodney D Newberry
Feb 24, 2012·Clinical Pharmacology and Therapeutics·Ingrid OrdásWilliam J Sandborn
Aug 24, 2012·Lancet·Daniel C Baumgart, William J Sandborn
Aug 24, 2012·Lancet·Ingrid OrdásWilliam J Sandborn
Feb 1, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Krista G HaanstraEric R Fedyk
May 23, 2013·JAMA : the Journal of the American Medical Association·Adam S Cheifetz
Aug 24, 2013·The New England Journal of Medicine·Brian G FeaganUNKNOWN GEMINI 1 Study Group
Aug 24, 2013·The New England Journal of Medicine·William J SandbornUNKNOWN GEMINI 2 Study Group
Nov 5, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jean-Frédéric ColombelXavier Hébuterne
Dec 17, 2014·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·K P Garnock-Jones
Dec 20, 2014·Scandinavian Journal of Gastroenterology·Robert V BryantSimon P L Travis
Apr 18, 2015·Pharmacotherapy·Parambir S DulaiBrian G Feagan
Nov 8, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Johannan F BrandseGeert R D'Haens
Feb 20, 2016·Gut·Jean-Frédéric ColombelBrian G Feagan
Jun 3, 2016·Journal of Crohn's & Colitis·Tim WyantBrihad Abhyankar
Jul 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Nicola FerriAlberto Corsini
Mar 24, 2017·Journal of Crohn's & Colitis·Erwin Dreesen, Ann Gils

❮ Previous
Next ❯

Citations

Jul 5, 2018·Expert Review of Gastroenterology & Hepatology·Jantien W WieringaC Janneke Van Der Woude
Mar 8, 2018·Clinical Pharmacokinetics·Luc J J DerijksAdriaan A van Bodegraven
Jan 3, 2019·Expert Opinion on Biological Therapy·Andras TarnokGabor Veres
Jan 24, 2019·European Journal of Gastroenterology & Hepatology·Claire LiefferinckxDenis Franchimont
Jul 18, 2019·Physiological Reviews·Michael BachmannBernhard Wehrle-Haller
Jul 20, 2019·Expert Review of Clinical Immunology·Ariela Holmer, Siddharth Singh
Sep 6, 2019·Current Gastroenterology Reports·Christopher M JohnsonThemistocles Dassopoulos
Nov 2, 2019·Crohn's & Colitis 360·Bharati KocharMichael D Kappelman
Oct 28, 2019·Minerva gastroenterologica e dietologica·Daniela PuglieseAlessandro Armuzzi
Jan 18, 2020·Expert Opinion on Biological Therapy·Ferdinando D'AmicoLaurent Peyrin-Biroulet
Jun 24, 2020·Scandinavian Journal of Gastroenterology·Neil K SenguptaNeeraj Narula
Jun 28, 2020·International Journal of Colorectal Disease·Mitchell R K L LieC Janneke van der Woude
Sep 25, 2019·Journal of Crohn's & Colitis·Miles P SparrowXavier Roblin
Nov 30, 2018·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Hang Hock ShimKhoon Lin Ling
Jul 23, 2020·Therapeutic Advances in Gastroenterology·Fabiana ZingoneEdoardo Vincenzo Savarino
Jun 28, 2018·The American Journal of Gastroenterology·Neeraj NarulaParambir S Dulai
May 19, 2018·Therapeutic Advances in Gastroenterology·Mark G WardXavier Roblin
Oct 28, 2017·Journal of Crohn's & Colitis·Tal EngelUri Kopylov
May 23, 2018·Inflammatory Bowel Diseases·Sophie RestelliniWaqqas Afif
Aug 10, 2020·AIDS·Jesper Damsgaard GunstOle Schmeltz Søgaard
Jan 27, 2019·Current Treatment Options in Gastroenterology·Christopher MaNiels Vande Casteele
Apr 18, 2020·Frontiers in Medicine·Joseph Meserve, Parambir Dulai
Feb 23, 2019·Expert Review of Gastroenterology & Hepatology·Christopher MaBrian Gordon Feagan
May 23, 2018·Inflammatory Bowel Diseases·Eugenia ShmidtParambir S Dulai
Dec 18, 2020·Clinical Pharmacology in Drug Development·Wan SunMaria Rosario
Jul 16, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Anne HuAshwin N Ananthakrishnan
Oct 27, 2020·Frontline Gastroenterology·Jonathan P SegalBu'Hussain Hayee
Dec 22, 2020·Frontiers in Physiology·Bernd Henning StumpfAna-Sunčana Smith
Oct 31, 2020·Gastroenterology Clinics of North America·Lillian Du, Christina Ha
Feb 18, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Parambir S DulaiCharlie Cao

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
flow cytometry

Software Mentioned

GEMINI
NONMEM

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.